A β-cyclodextrin "Click Cluster" decorated with seven paramagnetic chelates containing two water exchange sites

被引:81
作者
Bryson, Joshua M. [1 ]
Chu, Wen-Jang [2 ]
Lee, Jing-Huei [2 ,3 ]
Reineke, Theresa M. [1 ]
机构
[1] Virginia Tech, Dept Chem, Blacksburg, VA 24061 USA
[2] Univ Cincinnati, Dept Psychiat, Cincinnati, OH 45221 USA
[3] Univ Cincinnati, Dept Biomed Engn, Cincinnati, OH 45221 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1021/bc800200q
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The development of novel macromolecular contrast agents that offer enhanced relaxivity profiles at high magnetic fields have the potential to greatly improve the diagnosis, understanding, and treatment of disease. To this end, we have designed a monodiperse paramagnetic beta-cyclodextrin click cluster decorated with seven paramagnetic arms. A novel alkyne-functionalized diethylenetriaminetetraacetic acid (DTTA) chelate (6) has been created and coupled to a per-azido-beta-cyclodextrin core (7) to yield the precursor macromolecule (8). After removal of the protecting groups and fitrating with Gd, the final paramagnetic click cluster, Gd10, was obtained. Luminescence measurements were carried out in H2O and D2O on an analogous structure, Eu10, and indicated that at each lanthanide has an average of 1.8 water exchange sites, which is important for enhancing relaxivity and MRI resolution. This discrete paramagnetic click cluster yields a high relaxivity profile (43.4 mM(-1) s(-1) per molecule and 6.2 mM(-1) s(-1) per Gd3+ at 9.4 T) and enhanced contrast on a human MRI scanner as compared to a commercial agent, Magnevist (3.2 mM(-1) s(-1) at 9.4 T). Moreover, the useful inclusion properties exhibited by beta-cyclodextrin also make this an excellent host scaffold to functionalize via noncovalent assembly with receptor specific targeting moieties for biomolecular imaging.
引用
收藏
页码:1505 / 1509
页数:5
相关论文
共 29 条
[1]  
Aime S, 2001, CHEM-EUR J, V7, P5262, DOI 10.1002/1521-3765(20011217)7:24<5261::AID-CHEM5261>3.0.CO
[2]  
2-D
[3]   Amino acid derivatives of beta-cyclodextrin [J].
Ashton, PR ;
Koniger, R ;
Stoddart, JF ;
Alker, D ;
Harding, VD .
JOURNAL OF ORGANIC CHEMISTRY, 1996, 61 (03) :903-908
[4]   Impact of tumor-specific targeting and dosing schedule on tumor growth inhibition after intravenous administration of siRNA-containing nanoparticles [J].
Bartlett, Derek W. ;
Davis, Mark E. .
BIOTECHNOLOGY AND BIOENGINEERING, 2008, 99 (04) :975-985
[5]   Transferrin-containing, cyclodextrin polymer-based particles for tumor-targeted gene delivery [J].
Bellocq, NC ;
Pun, SH ;
Jensen, GS ;
Davis, ME .
BIOCONJUGATE CHEMISTRY, 2003, 14 (06) :1122-1132
[6]   CYCLODEXTRIN CHEMISTRY - SELECTIVE MODIFICATION OF ALL PRIMARY HYDROXYL-GROUPS OF ALPHA-CYCLODEXTRINS AND BETA-CYCLODEXTRINS [J].
BOGER, J ;
CORCORAN, RJ ;
LEHN, JM .
HELVETICA CHIMICA ACTA, 1978, 61 (06) :2190-2218
[7]   Gadolinium(III) chelates as MRI contrast agents: Structure, dynamics, and applications [J].
Caravan, P ;
Ellison, JJ ;
McMurry, TJ ;
Lauffer, RB .
CHEMICAL REVIEWS, 1999, 99 (09) :2293-2352
[8]   Strategies for increasing the sensitivity of gadolinium based MRI contrast agents [J].
Caravan, Peter .
CHEMICAL SOCIETY REVIEWS, 2006, 35 (06) :512-523
[9]   Synthesis of Nα-Boc-Nε-tetrabenzyl-DTPA-L-lysine and Nα-Fmoc-Nε-tetra-t-butyl-DTPA-L-lysine, building blocks for solid phase synthesis of DTPA-containing peptides [J].
Davies, JS ;
Al-Jamri, L .
JOURNAL OF PEPTIDE SCIENCE, 2002, 8 (12) :663-670
[10]   PRINCIPLES OF LANTHANIDE CHEMISTRY [J].
JOHNSON, DA .
JOURNAL OF CHEMICAL EDUCATION, 1980, 57 (07) :475-477